Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M, Kampmann P, Meijer K, O'Connell N, Pasi KJ, Hart DP, Kazmi R, Astermark J, Hermans CRJR, Klamroth R, Lemons R, Visweshwar N, von Drygalski A, Young G, Crary SE, Escobar M, Gomez E, Kruse-Jarres R, Quon DV, Symington E, Wang M, Wheeler AP, Gut R, Liu YP, Dolmetsch RE, Cooper DL, Li Y, Goldstein B, Monahan PE. Pipe SW, et al. Among authors: coppens m. N Engl J Med. 2023 Feb 23;388(8):706-718. doi: 10.1056/NEJMoa2211644. N Engl J Med. 2023. PMID: 36812434 Clinical Trial.
Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.
Miesbach W, Meijer K, Coppens M, Kampmann P, Klamroth R, Schutgens R, Tangelder M, Castaman G, Schwäble J, Bonig H, Seifried E, Cattaneo F, Meyer C, Leebeek FWG. Miesbach W, et al. Among authors: coppens m. Blood. 2018 Mar 1;131(9):1022-1031. doi: 10.1182/blood-2017-09-804419. Epub 2017 Dec 15. Blood. 2018. PMID: 29246900 Free PMC article. Clinical Trial.
Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrate.
Brekelmans MPA, Abdoellakhan RA, Scheres LJJ, Biedermann JS, Hutten BA, Meijer K, Cate HT, Huisman MV, Kruip MJHA, Middeldorp S, Coppens M. Brekelmans MPA, et al. Among authors: coppens m. Res Pract Thromb Haemost. 2017 Nov 13;2(1):77-84. doi: 10.1002/rth2.12055. eCollection 2018 Jan. Res Pract Thromb Haemost. 2017. PMID: 30046709 Free PMC article.
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
Schütte LM, Cnossen MH, van Hest RM, Driessens MHE, Fijnvandraat K, Polinder S, Beckers EAM, Coppens M, Eikenboom J, Laros-van Gorkom BAP, Meijer K, Nieuwenhuizen L, Mauser-Bunschoten EP, Leebeek FWG, Mathôt RAA, Kruip MJHA. Schütte LM, et al. Among authors: coppens m. BMJ Open. 2019 Apr 23;9(4):e022719. doi: 10.1136/bmjopen-2018-022719. BMJ Open. 2019. PMID: 31015264 Free PMC article.
BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease.
Atiq F, Fijnvandraat K, van Galen KPM, Laros-Van Gorkom BAP, Meijer K, de Meris J, Coppens M, Mauser-Bunschoten EP, Cnossen MH, van der Bom JG, Eikenboom J, Leebeek FWG; WiN study group. Atiq F, et al. Among authors: coppens m. Am J Hematol. 2019 Aug;94(8):E201-E205. doi: 10.1002/ajh.25499. Epub 2019 May 13. Am J Hematol. 2019. PMID: 31037771 Free PMC article. No abstract available.
Switching patients in the age of long-acting recombinant products?
Escobar M, Santagostino E, Mancuso ME, Coppens M, Balasa V, Taylor JA, Iorio A, Negrier C. Escobar M, et al. Among authors: coppens m. Expert Rev Hematol. 2019;12(sup1):1-13. doi: 10.1080/17474086.2018.1564032. Expert Rev Hematol. 2019. PMID: 31282771 Review.
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P® /Humate P® treatment in von Willebrand disease patients.
de Jager NCB, Bukkems LH, Heijdra JM, Hazendonk CHCAM, Fijnvandraat K, Meijer K, Eikenboom J, Laros-van Gorkom BAP, Leebeek FWG, Cnossen MH, Mathôt RAA; OPTI-CLOT group. de Jager NCB, et al. J Thromb Haemost. 2020 Feb;18(2):295-305. doi: 10.1111/jth.14652. Epub 2019 Oct 21. J Thromb Haemost. 2020. PMID: 31557387 Free PMC article.
Patient Perspectives on Novel Treatments in Haemophilia: A Qualitative Study.
van Balen EC, Wesselo ML, Baker BL, Westerman MJ, Coppens M, Smit C, Driessens MHE, Leebeek FWG, van der Bom JG, Gouw SC. van Balen EC, et al. Among authors: coppens m. Patient. 2020 Apr;13(2):201-210. doi: 10.1007/s40271-019-00395-6. Patient. 2020. PMID: 31691206 Free PMC article.
Optimal trough levels in haemophilia B: Raising expectations.
Walsh C, Coppens M, Escobar M, Wang M. Walsh C, et al. Among authors: coppens m. Haemophilia. 2020 Nov;26(6):e334-e336. doi: 10.1111/hae.14098. Epub 2020 Aug 25. Haemophilia. 2020. PMID: 32842166 Free PMC article. No abstract available.
Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study.
Schep SJ, van Dijk WEM, Beckers EAM, Meijer K, Coppens M, Eikenboom J, Leebeek FWG, van Vulpen LFD, Fischer KF, Schutgens REG; Dutch Society of Haemophilia Treaters, The Netherlands. Schep SJ, et al. Among authors: coppens m. Am J Hematol. 2021 Jan;96(1):51-59. doi: 10.1002/ajh.26009. Epub 2020 Oct 10. Am J Hematol. 2021. PMID: 32974947 Free PMC article.
306 results